PCNA and neoplasm: In addition, cells immunoreactive for the proliferation marker PCNA were significantly decreased in the treated tumor masses compared with the normal saline-treated tumor masses, and anlotinib combined with chemoradiation treatment resulted in the lowest PCNA levels (Figure 12).